Alphamab (Australia) Co Pty Ltd.
2 clinical trials · Sponsor
◉ Watch Alphamab (Australia) Co Pty Ltd.
| Record | Firm | Date |
|---|---|---|
| First-In-Human Study in Subjects With Advanced or Metastatic Solid Malignant Tumors (NCT05494918) | Alphamab (Australia) Co Pty Ltd. | 2022-09-02 |
| Study of the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Antitumor Activity of KN046 in Subjects With Advanced Solid Tumors (NCT03529526) | Alphamab (Australia) Co Pty Ltd. | 2018-05-21 |
Track Alphamab (Australia) Co Pty Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.